NCT05465187

Brief Summary

Intensive care has known an important scientists progress for the last twenty years, allowing to heal more and more severe patients. Throughout the time, population has been getting old more and more, making patients affected by several diseases. As any medical specialty, intensive care has been confronted to these both evolutions. Thus ethical issues subsist for many years concerning rationality of cares intensity given to the patients. Withholding or withdrawing of life-sustaining therapy represents a non-negligible part of deaths in intensive care units in France. Throughout the years, it has been more and more leading French laws, as the Clayes-Leonetti law, one of the most important and recent one, which has governed ending life patients' rights since 2016. Thus it appears interesting to propose this study to evaluate proportion of withholding or withdrawing of life-sustaining therapy and their conditions of setting up in a maximum of intensive care units in the Grand-Est region in France in 2022 ; and to collect family's feelings concerning these decisions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 19, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

April 3, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2023

Completed
Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

7 months

First QC Date

July 18, 2022

Last Update Submit

February 6, 2025

Conditions

Keywords

Intensive carefamily's feelings

Outcome Measures

Primary Outcomes (1)

  • Incidence of withholding or withdrawing of life-sustaining therapy

    The primary outcome measure will consist in determine the part of withholding or withdrawing of life-sustaining therapy measures in Grand Est French ICU to learn about their importance. Thus we can compare it to data we know from previous studies first. Second, we can evaluate the evolution throughout the time if there is one and the impact of new laws for example.

    Day 28

Secondary Outcomes (3)

  • Conditions of setting up withholding or withdrawing of life-sustaining therapy

    during the month of study

  • Agreement of these decisions with currently French legislation (" Claeys-Leonetti " lay, 2016)

    at the inclusion of the patients in the study

  • Questionnaire Family Satisfaction with ICU - 24Revisited

    during the month of study

Study Arms (1)

Patients

Adults patients aged for more than 18 years old, admitted in an intensive care unit in Grand-Est region in France, for whom a decision of withholding or withdrawing of life-sustaining therapy is taken during the month of study.

Other: Non applicable

Interventions

Non applicable

Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults patients aged for more than 18 years old hospitalized in an intensive care unit in Grand-Est region in France during the month of study, for whom a decision of withholding or withdrawing of life-sustaining therapy is taken during the month of study. Contentment of the patient or their confident person must be collected to allow inclusion.

You may qualify if:

  • Adults patients hospitalized in an intensive care unit in Grand-Est region in France
  • For whom a decision of withholding or withdrawing of life-sustaining therapy is taken during the month of study
  • Contentment of the patient or their support person collected.

You may not qualify if:

  • Patients aged less than 18 years old
  • Who already have a decision of withholding or withdrawing of life-sustaining therapy taken before the beginning of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2022

First Posted

July 19, 2022

Study Start

April 3, 2023

Primary Completion

November 2, 2023

Study Completion

November 2, 2023

Last Updated

February 7, 2025

Record last verified: 2025-02

Locations